Human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) are bloodborne and transmitted primarily through sexual contact and injection drug use (IDU). They have shared routes of transmission and therefore involve not only risk of infection for each of the three viruses but also coinfection. Studies have demonstrated increased liver-related deaths among coinfected individuals, which is a leading cause of death in HIV-infected individuals. Other complications include kidney disease, cardiovascular disease, metabolic disorders, and bone complications.
The goal of the CME Outfitters Infectious Disease Hub is to provide clinicians and patients with access to education in order to address the challenges in screening and treating patients with HIV and/or HBV/HCV. Links to dedicated patient education hubs offer tools to improve health literacy and engage patients to be active participants in their treatment plan.
In this recorded CME Outfitters webcast, expert faculty focus on universal HBV screening with triple panel testing to accurately identify patients with active HBV infection. The faculty also present strategies and best practices for linking patients with HBV to appropriate medical care based on interpretation of serological test results while factoring in SDoH.
In this CMEO Snack, join expert faculty as they discuss best strategies to identify risk factors of CMV infection, recognize the impact of CMV on treatment outcomes, and ultimately develop balanced treatment plans for patients with CMV disease.
This CMEO BriefCase will introduce a complex case involving treatment and management considerations for a patient with HIV and HCV. Join Drs. Nancy Reau and Christian Ramers as they explore the epidemiology and shared pathobiology of liver fibrosis in HIV/HCV, real-world data for available therapies, contraindicated agent combinations, and when and how to treat.
This CMEO BriefCase will introduce a complex HCV case involving a patient with HCV and chronic kidney disease (CKD). Join Drs. Nancy Reau and Anthony Martinez as they dive deeper into treatment and management considerations for such patients, focusing on screening, diagnosis, and risk factors as well as the epidemiology and shared pathobiology of HCV and CKD.
This CMEO BriefCase will introduce a case involving the incorporation of routine surveillance for HCC in a patient with HCV. Join our faculty experts as they delve into the epidemiology and shared pathobiology of HCV and decompensated cirrhosis, identify compensated versus decompensated cirrhosis, and discuss surveillance strategies for HCC.
Access additional videos and resources on infectious diseases for both clinicians and patients.